First-in-human phase I/Ib study of the oral Werner (WRN) helicase inhibitor HRO761 in patients (pts) with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors
用户Iyw2nMKTP_RA
12天前
52
10
已完结
1. 系统已在2025-12-31 15:41:29对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.annonc.2025.08.1494
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0923753425024147
其他信息:
出版社: Elsevier BV
作者: M.B.B. Foote; J. Li; D.S. Tan; P.A. Calvo Ferrandiz; R. Galot; E. Garralda; T.K.K. Guren; A. Italiano; C-C. Lin; Z.A.A. Wainberg; J. Yachnin; T.A. Yap; R. de Kanter; N. Grande; A. Izaac; D. Jankovic; L. Sansregret; C. Zhang; A.K. Nagaraja; Y. Kuboki
